A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients
Clinical trial NCT05758610 · UNKNOWN
Trial details
- NCT number
- NCT05758610
- Sponsor
- Shengke Pharmaceuticals (Jiangsu) Limited, China
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-04
- Primary completion
- 2025-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.